A study published as an abstract in 2018 included 50 breast cancer patients with brain metastases, in which ER-positive HER2-positive tumors showed a higher rate of cerebellar metastasis (P < 0.05) [23]. This evidence concerns the gene ERBB2 and breast cancer.